Standard BioTools gets Nasdaq notice for failing $1 minimum bid price rule
LAB•Nasdaq notice for minimum bid price rule
- Standard BioTools received a Nasdaq notice for failing the $1 minimum bid price rule after 30 straight business days below $1.
- Shares keep trading on the Nasdaq Global Select Market under
LAB; no immediate impact on listing status. - The deadline to regain compliance is Jan. 19, 2027, requiring a $1+ closing bid for at least 10 consecutive business days.
- An extra 180-day cure period may be available if the company transfers to the Nasdaq Capital Market; a reverse split remains an option.
Related News
BBRC International disposes of 289,479 Victoria’s Secret shares worth $25.73 million
VSCO•
Cartesian Growth II postpones shareholder meeting to July 30 from July 27
RENEF•
